Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_assertion description "[Leukemia cells with low levels of MSH2 contained partial or complete somatic deletions of one to four genes that regulate MSH2 degradation (FRAP1 (also known as MTOR), HERC1, PRKCZ and PIK3C2B); we also found these deletions in individuals with adult acute lymphoblastic leukemia (16%) and sporadic colorectal cancer (13.5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_assertion evidence source_evidence_literature NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_assertion SIO_000772 21946537 NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_assertion wasDerivedFrom befree-20140225 NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_assertion wasGeneratedBy ECO_0000203 NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP291657.RA51KPDmjt8NmZf69HNV-Gp7xpBm1ZDHS8Ho-a996HXMU130_provenance.